Comparison
5p Partial Monosomy Syndrome C0010314 vs 2 Hydroxyadipic Aciduria C5826412
Clinical comparison between 5P Partial Monosomy Syndrome and 2 Hydroxyadipic Aciduria for differential diagnosis and treatment planning.
5p Partial Monosomy Syndrome C0010314
Also called Cri-du-chat syndrome, caused by a deletion on chromosome 5. Features include a high-pitched cry, developmental delay, and intellectual disability.
2 Hydroxyadipic Aciduria C5826412
A metabolic condition where certain acids accumulate abnormally. It can impact energy metabolism and neurological function. Treatment typically involves dietary modifications and monitoring.
6 comparison axes
Onset
5p Partial Monosomy Syndrome C0010314
0-0
2 Hydroxyadipic Aciduria C5826412
0-null
Onset patterns differ
Severity
5p Partial Monosomy Syndrome C0010314
severe
2 Hydroxyadipic Aciduria C5826412
moderate
Different severity levels
Chronic
5p Partial Monosomy Syndrome C0010314
Chronic
2 Hydroxyadipic Aciduria C5826412
Chronic
Differing course
Communicable
5p Partial Monosomy Syndrome C0010314
No
2 Hydroxyadipic Aciduria C5826412
No
Different transmission
Body System
5p Partial Monosomy Syndrome C0010314
congenital
2 Hydroxyadipic Aciduria C5826412
metabolic
Same/different system
Category
5p Partial Monosomy Syndrome C0010314
genetic
2 Hydroxyadipic Aciduria C5826412
metabolic
Different category
Bottom line
5p-partial-monosomy-syndrome-C0010314 and 2-hydroxyadipic-aciduria-C5826412 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 5p Partial Monosomy Syndrome C0010314 | 2 Hydroxyadipic Aciduria C5826412 | Discriminating power |
|---|---|---|---|
| Early cry or neurologic presentation | High-pitched cat-like cry may be present from birth with developmental delay. | No characteristic cry is established; neurologic effects may occur if metabolism is disturbed. | High |
| Developmental course | Intellectual disability and developmental delay are core described features. | Neurologic impact is possible, but a uniform developmental pattern is not established. | Moderate |
| Metabolic clues | Not primarily described as an organic-acid accumulation disorder. | Abnormal accumulation of certain acids is the defining metabolic feature. | High |
When to favor each condition
Choose 5p Partial Monosomy Syndrome C0010314 when
Congenital features and characteristic cry
A chromosome 5 deletion better explains a birth-onset syndrome with the described cry and developmental disability.
High
Confirmed chromosomal deletion
Genetic testing showing partial monosomy 5 supports this diagnosis over a metabolic aciduria.
High
Severe lifelong developmental disability
The supplied severity is severe and the course is chronic, although individual outcomes vary.
Moderate
Choose 2 Hydroxyadipic Aciduria C5826412 when
Abnormal organic-acid result
Acid accumulation points toward a metabolic process, but an abnormal result alone is not a complete diagnosis.
Moderate
Suspected energy-metabolism disorder
The source links this condition to energy metabolism and possible neurologic effects.
Moderate
Dietary management is being considered
Management is typically described as dietary modification and monitoring, directed by a specialist.
Moderate
How key tests differ
| Test | 5p Partial Monosomy Syndrome C0010314 | 2 Hydroxyadipic Aciduria C5826412 | Interpretation |
|---|---|---|---|
| Chromosomal microarray or karyotype | May show a deletion involving chromosome 5. | Not expected to establish this metabolic condition. | A confirmed deletion supports Cri-du-chat; absence does not explain an aciduria. |
| Urine organic-acid analysis | No specific organic-acid pattern is established by the source. | May show abnormal accumulation of relevant acids; exact cutoffs are not supplied. | Interpret with a metabolic specialist; an abnormal value is not automatically a diagnosis. |
| Neurologic and developmental assessment | Often documents developmental delay and intellectual disability. | May show neurologic effects, but findings are not specifically defined here. | Assessment supports care planning but does not distinguish etiology alone. |
Prognosis comparison
5p Partial Monosomy Syndrome C0010314
- Outcome
- Generally a severe chronic congenital condition with developmental disability; exact outcomes vary.
- Factors
- Deletion characteristics, associated congenital findings, and access to supportive care may influence function.
2 Hydroxyadipic Aciduria C5826412
- Outcome
- Described as moderate and chronic, but long-term outcome is not established here.
- Factors
- Degree of metabolic disturbance, neurologic involvement, and response to monitoring may matter.
Time frame: Both are described as chronic; precise milestones or survival data are not supplied.
Etiology, severity, developmental needs, and specialist follow-up are the main available factors.
Complications comparison
| Complication | Presentation |
|---|---|
| Neurodevelopment | Developmental delay and intellectual disability are established features. Neurologic function may be affected, with severity not fully defined. Both can need developmental support, but mechanisms differ. |
| Feeding or nutrition | Feeding difficulty may occur in infants, though details are not supplied here. Dietary modification and monitoring are typical management elements. Nutrition plans should be individualized and not inferred as identical. |
| Long-term medical complexity | Described as severe and chronic. Described as moderate and chronic. Supplied severity differs, but individual prognosis is not established. |
Patient education highlights
- HighDifferent causes
One is a chromosome deletion present from birth; the other involves abnormal acid metabolism. Neither is communicable.
- HighTesting meaning
A genetic result and a metabolic laboratory result answer different questions and require clinician interpretation.
- MediumSupportive care
Developmental, neurologic, and nutrition follow-up may be needed. No treatment dose or exact diet can be specified from these data.